2452-1094

Advances in Radiation Oncology

Elsevier

View prefix report (10.1016)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 1870 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact1870 DOIs
2

Attach ORCID iDs across 655 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact655 DOIs
3

Deposit reference lists for 75 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact75 DOIs

DOIs for this ISSN

Showing the top 5 of 1870 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Role of the immunosuppressive microenvironment in immunother… (10.1016/j.adro.2018.08.018)
Abstract ORCID
112.64 178
2 Stereotactic MR-Guided Online Adaptive Radiation Therapy (SM… (10.1016/j.adro.2018.10.003)
Abstract ORCID
111.14 166
3 Field size effects on the risk and severity of treatment-ind… (10.1016/j.adro.2018.08.014)
Abstract ORCID
109.93 157
4 A Multi-Institutional Experience of MR-Guided Liver Stereota… (10.1016/j.adro.2018.08.005)
Abstract ORCID
108.51 147
5 Prostate Cancer Radiation Therapy Recommendations in Respons… (10.1016/j.adro.2020.03.010)
Abstract ORCID
106.36 133
6 Two-and-a-half-year clinical experience with the world's fir… (10.1016/j.adro.2017.05.006)
Abstract ORCID
105.86 130
7 A Comparison of Grade 4 Lymphopenia With Proton Versus Photo… (10.1016/j.adro.2018.09.004)
Abstract ORCID
97.47 88
8 The development, commercialization, and clinical context of… (10.1016/j.adro.2016.08.003)
Abstract ORCID
96.72 85
9 Comparison of outcomes between SBRT, yttrium-90 radioemboliz… (10.1016/j.adro.2015.12.003)
Abstract ORCID
96.21 83
10 Breast Radiation Therapy Under COVID-19 Pandemic Resource Co… (10.1016/j.adro.2020.03.013)
Abstract ORCID
95.42 80
11 Single-Isocenter Multitarget Stereotactic Radiosurgery Is Sa… (10.1016/j.adro.2019.08.013)
Abstract ORCID
93.46 73
12 Achieving gender equity in the radiation oncology physician… (10.1016/j.adro.2018.09.003)
Abstract ORCID
92.56 70
13 Phase 1 trial of preoperative image guided intensity modulat… (10.1016/j.adro.2016.12.003)
Abstract ORCID
91.63 67
14 The big data effort in radiation oncology: Data mining or da… (10.1016/j.adro.2016.10.001)
Abstract ORCID
91.30 66
15 Evaluation of Mobile Health Applications to Track Patient-Re… (10.1016/j.adro.2020.09.016)
Abstract ORCID
91.30 66
16 External beam radiation therapy for advanced/unresectable ma… (10.1016/j.adro.2017.11.002)
Abstract ORCID
89.97 62
17 Distant intracranial failure in melanoma brain metastases tr… (10.1016/j.adro.2017.07.003)
Abstract ORCID
89.62 61
18 Radiation-induced erectile dysfunction: Recent advances and… (10.1016/j.adro.2016.05.003)
Abstract ORCID
89.27 60
19 Fractionated stereotactic radiation therapy for intact brain… (10.1016/j.adro.2017.07.006)
Abstract ORCID
89.27 60
20 Generating antitumor immunity by targeted radiation therapy:… (10.1016/j.adro.2018.08.021)
Abstract ORCID
88.17 57
21 Viability of Noncoplanar VMAT for liver SBRT compared with c… (10.1016/j.adro.2015.12.004)
Abstract ORCID
87.79 56
22 Machine Learning Methods Uncover Radiomorphologic Dose Patte… (10.1016/j.adro.2018.11.008)
Abstract ORCID
87.79 56
23 Stereotactic body radiotherapy (SBRT) for locally advanced e… (10.1016/j.adro.2016.10.008)
Abstract ORCID
87.41 55
24 The Impact of COVID-19 on Radiation Oncology Clinics and Pat… (10.1016/j.adro.2020.03.006)
Abstract ORCID
87.02 54
25 Multiple energy extraction reduces beam delivery time for a… (10.1016/j.adro.2018.02.006)
Abstract ORCID
86.62 53
26 Postoperative radiation therapy is associated with a reduced… (10.1016/j.adro.2016.10.003)
Abstract ORCID
85.38 50
27 Predictors of radiation-induced acute skin toxicity in breas… (10.1016/j.adro.2017.10.007)
Abstract ORCID
85.38 50
28 Factors influencing prostate cancer patterns of care: An ana… (10.1016/j.adro.2017.12.008)
Abstract ORCID
85.38 50
29 Single fraction stereotactic radiosurgery for multiple brain… (10.1016/j.adro.2017.09.002)
Abstract ORCID
84.95 49
30 Radiation Therapy Practice Patterns for Brain Metastases in… (10.1016/j.adro.2019.07.012)
Abstract ORCID
84.95 49
31 Updated strategies in the treatment of benign diseases—a pat… (10.1016/j.adro.2018.02.008)
Abstract ORCID
84.51 48
32 The pervasive crisis of diminishing radiation therapy access… (10.1016/j.adro.2017.07.002)
Abstract ORCID
83.14 45
33 Use of mobile device technology to continuously collect pati… (10.1016/j.adro.2016.02.001)
Abstract ORCID
82.66 44
34 A Novel Salvage Option for Local Failure in Prostate Cancer,… (10.1016/j.adro.2020.04.022)
Abstract ORCID
82.66 44
35 Long-term outcomes and toxicities of a large cohort of anal… (10.1016/j.adro.2017.01.009)
Abstract ORCID
82.17 43
36 Intensity modulated radiation therapy for squamous cell carc… (10.1016/j.adro.2017.02.006)
Abstract ORCID
82.17 43
37 Long-Term Institutional Experience With Telemedicine Service… (10.1016/j.adro.2020.04.018)
Abstract ORCID
82.17 43
38 A Multi-Institutional Experience of Proton Beam Therapy for… (10.1016/j.adro.2019.07.008)
Abstract ORCID
81.67 42
39 Abscopal effect in recurrent colorectal cancer treated with… (10.1016/j.adro.2017.06.001)
Abstract ORCID
80.64 40
40 Adjuvant radiation for salivary gland malignancies is associ… (10.1016/j.adro.2017.03.008)
Abstract ORCID
80.10 39
41 First-In-Human Phase 1 Study of a Nonwoven Fabric Bioabsorba… (10.1016/j.adro.2019.05.002)
Abstract ORCID
80.10 39
42 A prospective study of quality of life in breast cancer pati… (10.1016/j.adro.2016.01.003)
Abstract ORCID
79.55 38
43 Pathologic response after neoadjuvant chemotherapy predicts… (10.1016/j.adro.2017.01.012)
Abstract ORCID
79.55 38
44 SBRT to adrenal metastases provides high local control with… (10.1016/j.adro.2017.07.011)
Abstract ORCID
79.55 38
45 Toxicity of radiation and immunotherapy combinations (10.1016/j.adro.2018.08.003)
Abstract ORCID
79.55 38
46 Continuing Medical Student Education During the Coronavirus… (10.1016/j.adro.2020.05.006)
Abstract ORCID
79.55 38
47 Prediction of Survival and Recurrence Patterns by Machine Le… (10.1016/j.adro.2020.07.007)
Abstract ORCID
78.99 37
48 Effects of vertebral-body-sparing proton craniospinal irradi… (10.1016/j.adro.2017.03.001)
Abstract ORCID
78.41 36
49 Premature discontinuation of curative radiation therapy: Ins… (10.1016/j.adro.2017.10.006)
Abstract ORCID
78.41 36
50 Safety of combining thoracic radiation therapy with concurre… (10.1016/j.adro.2018.05.001)
Abstract ORCID
78.41 36